AKF

American Kidney Fund Launches National Kidney Health Equity Media Campaign

Retrieved on: 
星期四, 四月 25, 2024
Kidney disease, University, Radio, Kidney failure, Trustee, National TV, American Kidney Fund, Pancreas transplantation, Dialysis, AKF, Contextual advertising, Eli Lilly and Company, All, Therapy, PSAS, AstraZeneca, Prevalence, Vertex Pharmaceuticals, Pharmaceutical industry

ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at bringing greater awareness of kidney disease within Black and Hispanic/Latino communities, the two groups most disproportionately affected by kidney failure in the United States.

Key Points: 
  • ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at bringing greater awareness of kidney disease within Black and Hispanic/Latino communities, the two groups most disproportionately affected by kidney failure in the United States.
  • A central piece of AKF’s Kidney Health for All™ program, this yearlong campaign focuses on prevention and disease management and will include national TV, streaming and radio PSAs, digital advertising, video in primary care doctor’s offices, and ads on billboards and public transit in metropolitan areas with high rates of kidney disease.
  • “Our message is clear: ‘We don’t just believe in Kidney Health for All – we work to achieve it,’” said LaVarne A. Burton, AKF President and CEO.
  • “Through these awareness efforts, we hope to educate Americans, particularly those in communities where rates of end-stage kidney disease are high, that dialysis is not evitable.

American Kidney Fund Recognized as a Top Nonprofit Workplace in the United States

Retrieved on: 
星期二, 四月 23, 2024
Kidney disease, Nonprofit organization, The NonProfit Times, Work, American Kidney Fund, AKF, Workforce, Philosophy, Management

This is the third year AKF has earned a spot on this annual list, which identifies nonprofit organizations that have gone above and beyond to create quality workplaces.

Key Points: 
  • This is the third year AKF has earned a spot on this annual list, which identifies nonprofit organizations that have gone above and beyond to create quality workplaces.
  • The survey and awards program is designed to identify, recognize and honor the best employers in the nonprofit industry, benefiting the industry's economy, workforce and businesses.
  • Nonprofits from across the United States participated in a two-part survey process to determine Best Nonprofits to Work For.
  • For more information on The Nonprofit Times’ Best Nonprofits to Work For program, visit https://www.bestnonprofitstoworkfor.com/ .

American Kidney Fund Awards Fellowships to Researchers Studying Acute Interstitial Nephritis and Pulmonary Hypertension in Kidney Patients

Retrieved on: 
星期四, 四月 11, 2024
Urine, Kidney disease, Cancer, Biomedical sciences, Inflammation, Biostatistics, MD–PhD, Kidney, Research fellow, Pulmonary hypertension, Nephritis, Risk, Hope, Blood, Clinical scientist, Epidemiology, Death, Immunotherapy, Clinical and Translational Science, MD, Research, Yale University, CSN, CKD, American Kidney Fund, Patient, Kidney transplantation, Bachelor of Arts, Dialysis, AKF, Diagnosis, Immune system, Chronic kidney disease, Heart failure, Pharmaceutical industry

However, it is common in patients with CKD, with approximately 21% of CKD patients having pulmonary hypertension.

Key Points: 
  • However, it is common in patients with CKD, with approximately 21% of CKD patients having pulmonary hypertension.
  • "Pulmonary hypertension is a common and underrecognized issue for patients with chronic kidney disease,” said Dr. Tuttle.
  • “Through this study, I plan to identify new risk factors for pulmonary hypertension in patients with chronic kidney disease.
  • Her current research focuses on the development of pulmonary hypertension in patients with chronic kidney disease.

American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated Kidney Disease (AMKD) on Capitol Hill

Retrieved on: 
星期二, 四月 9, 2024
American Kidney Fund, African Americans, Health, Apolipoprotein L1, L1, APOL1, Genetic testing, Disease, Risk, Policy, Black, Kidney disease, Vertex Pharmaceuticals, AKF, Pharmaceutical industry

ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness of this rapidly progressive form of genetic kidney disease.

Key Points: 
  • ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness of this rapidly progressive form of genetic kidney disease.
  • The roundtable is being held in conjunction with the nation’s first ever AMKD Awareness Day , which AKF is launching on April 30, 2024.
  • “For many years, I have publicly shared my personal kidney disease story to help educate people about APOL1-mediated kidney disease,” said Mourning.
  • Also participating in the roundtable discussion are:
    Support for AMKD Awareness Day activities, including this roundtable discussion, is provided by Vertex Pharmaceuticals Incorporated.

American Kidney Fund Launches Phosphorus Management Education and Awareness Campaign

Retrieved on: 
星期二, 三月 19, 2024
Phosphorus, Hyperphosphatemia, American Kidney Fund, Disease, Education, Patient, Cramp, Kidney failure, Kidney disease, Diet, AKF, Skin, Dialysis, Blood

ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a new patient-focused educational awareness campaign on managing high phosphorus, also known as hyperphosphatemia.

Key Points: 
  • ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a new patient-focused educational awareness campaign on managing high phosphorus, also known as hyperphosphatemia.
  • AKF’s phosphorus management education campaign will work to raise awareness among dialysis patients about why phosphorus levels matter, ways to manage phosphorus intake with low phosphorus foods and fluids, and information about existing and new phosphate lowering medications, including phosphate blockers.
  • The campaign will provide people with a host of resources, including a patient-facing education page on AKF’s website; a page on AKF’s nutrition website, Kidney Kitchen ®; downloadable guides on talking to your doctor about phosphorus and low phosphorus foods; and a patient-facing session on hyperphosphatemia management at Kidney Action Week 2024 .
  • We hope that this campaign provides much-needed information to patients and families and can make an impact on their disease management.”

American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22

Retrieved on: 
星期一, 三月 18, 2024
American Kidney Fund, Patient, Nephrology, Kidney disease, AKF, Caregiver

ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week ™, the nation’s only free online conference that draws patients, caregivers, nephrologists, researchers and other experts to participate in a weeklong series of sessions related to kidney disease.

Key Points: 
  • ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week ™, the nation’s only free online conference that draws patients, caregivers, nephrologists, researchers and other experts to participate in a weeklong series of sessions related to kidney disease.
  • More than 5,000 people are expected to participate in 2024 Kidney Action Week.
  • The event is part of AKF’s Kidney Month observance, which is focused on equipping and empowering people with the tools they need to prioritize their kidney health and fight kidney disease.

American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Against Kidney Disease

Retrieved on: 
星期五, 三月 15, 2024
American Kidney Fund, Candid (organization), Disease, Caregiver, Vertex Pharmaceuticals, Risk, GSK, Boehringer Ingelheim, GSK plc, Kidney disease, AKF, Therapy, Kidney, Eli Lilly and Company, Platinum, Charity Navigator, Corporation, Pharmaceutical industry

ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .

Key Points: 
  • ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .
  • Corporate Members provide essential support to AKF as it continues its fight against kidney disease on all fronts—from prevention through post-transplant living.
  • “Our Corporate Members—both new and returning—help make the work AKF does for the kidney community possible,” said LaVarne A. Burton, AKF President and CEO.
  • Corporate Members fund AKF’s essential work, including:
    Award-winning, evidence-based kidney health education resources that reach millions of people living with kidney disease, caregivers, living organ donors and health care providers each year
    The Corporate Membership Program is open to institutional partners that support AKF’s mission of fighting kidney disease and helping people live healthier lives.

Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease

Retrieved on: 
星期四, 二月 29, 2024
AstraZeneca, Caregiver, American Kidney Fund, Eli Lilly and Company, AKF, Dialysis, Pfizer, Notifiable disease, Nephrology, Boehringer Ingelheim, Patient, Genetic testing, Kidney disease, Senior counsel, Disease, Kidney, Diagnosis, Research, Kidney failure, Pharmaceutical industry

During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.

Key Points: 
  • During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.
  • One of the hallmarks of Kidney Month at AKF is Kidney Action Week , which will be held March 18-22.
  • This free, virtual event will bring together patients, nephrologists, renal dieticians, caregivers and other kidney experts for a weeklong series of sessions about a variety of topics related to kidney disease, including dialysis, kidney disease prevention, kidney-friendly eating, transplant, innovations in kidney disease and more.
  • In addition, people with kidney disease have a higher chance of developing other health problems, such as heart disease.

Where You Live Impacts Your Ability to Save a Life Through Living Organ Donation, According to the 2024 American Kidney Fund Report Card

Retrieved on: 
星期四, 二月 22, 2024
Ambassador, Chronic kidney disease, Health insurance, American Kidney Fund, Latino, AKF, Dialysis, News, Report card, Transplant, Skin, Life, HIPP, CKD, Disability, House, FMLA, Telephone numbers in Hungary, Policy, Family, Legislation, Louisiana House of Representatives, Patient, Kidney disease, Insurance, Kidney, Representative, Child, Health equity, The Report Card, Mortality, Research, Senate, Kidney failure

Receiving a kidney from a living donor is the best option for someone in need of a new kidney.

Key Points: 
  • Receiving a kidney from a living donor is the best option for someone in need of a new kidney.
  • However, six states – Alabama, Montana, New Hampshire, Tennessee, South Dakota and Vermont – have zero policy protections (F grade) for living organ donors.
  • How All 50 States + DC Fared on the 2024 State of the States: American Kidney Fund Report Card
    Currently, chronic kidney disease (CKD) affects more than 1 in 7 adults in the U.S.
  • “Where you live should not impact whether you are able to save a life through kidney donation, but our 2024 Report Card suggests that this may be the case.

American Kidney Fund Announces April 30 as the First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day

Retrieved on: 
星期四, 一月 25, 2024
Vertex Pharmaceuticals, Apolipoprotein L1, Dialysis, Central African, Focal segmental glomerulosclerosis, Kidney failure, Health, Foreign policy, Kidney, FSGS, APOL1, Gene, AKF, Risk, Kidney disease, Genetic testing, Mutation, Disease, Congress, L1, Education, American Kidney Fund, Pharmaceutical industry

ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .

Key Points: 
  • ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .
  • Building on AKF’s educational campaign for the condition, AMKD Awareness Day aims to spread awareness of APOL1-mediated kidney disease (AMKD) , a spectrum of kidney diseases associated with variants (mutations) in the apolipoprotein L1 (APOL1) gene and linked to an increased risk for rapidly progressing kidney disease in people of Western and Central African descent.
  • People with two mutations are at higher risk of developing genetic forms of kidney disease such as focal segmental glomerulosclerosis (FSGS).
  • Additionally, AKF will provide resources and ways to engage and raise awareness of the important connection between APOL1 gene variants and kidney disease in the months ahead.